Emergency Room Treatment for Migraine
For most migraine sufferers presenting to the emergency room, first-line therapy should be nonsteroidal anti-inflammatory drugs (NSAIDs), with triptans as second-line therapy for those who don't respond to NSAIDs. 1
First-Line Treatment Options
NSAIDs
- Recommended options:
- Ibuprofen (400-800mg)
- Naproxen sodium (500mg)
- Aspirin
- Combination of acetaminophen + aspirin + caffeine 1
Note: There is no evidence supporting the use of acetaminophen alone for migraine treatment 1
Administration Considerations
- If significant nausea or vomiting is present, select a non-oral route of administration 1
- Treat nausea with an antiemetic (e.g., metoclopramide, prochlorperazine) even if the patient is not actively vomiting 1
- Antiemetics serve dual purposes:
- Treating the nausea component of migraine
- Allowing for better absorption of oral medications
Second-Line Treatment: Migraine-Specific Agents
If NSAIDs fail to provide adequate relief, use migraine-specific agents:
Triptans
- Sumatriptan options:
Important: Subcutaneous administration provides the most rapid pain relief compared to other routes 4
- Other effective triptans:
- Oral naratriptan
- Oral rizatriptan
- Oral zolmitriptan 1
Dihydroergotamine (DHE)
- DHE nasal spray is an effective alternative 1
Treatment Algorithm
- Start with NSAIDs unless contraindicated
- Add antiemetic if nausea is present (regardless of vomiting)
- Switch to triptan if no response to NSAIDs within 2 hours
- Consider subcutaneous sumatriptan for fastest relief in severe cases
- Second dose of triptan may be administered if migraine returns after initial improvement (wait at least 2 hours between doses) 2
Dosing Considerations
Sumatriptan Dosing
- Oral: 50mg is optimal for balance of efficacy and tolerability; 100mg may be more effective but has more side effects 2, 3
- Maximum daily dose: 200mg in a 24-hour period 2
- For patients with hepatic impairment: Maximum single dose should not exceed 50mg 2
Safety Considerations
- Contraindications for triptans: History of ischemic heart disease 5
- Common adverse events: Generally mild and short-lived 5
- Oral sumatriptan: Nausea, vomiting, malaise, fatigue
- Subcutaneous sumatriptan: Injection site reactions (10-40% of patients)
- Intranasal sumatriptan: Bitter taste at back of mouth 6
- Serious adverse events: Occur in approximately 0.14% of patients 6
- Warning: Regular use of analgesics may lead to medication overuse headache
Prevention Considerations
While treating the acute attack in the ER, consider evaluating the patient for preventive therapy if they have:
- Two or more attacks per month with disability lasting 3+ days per month
- Contraindication to or failure of acute treatments
- Use of abortive medication more than twice per week
- Presence of uncommon migraine conditions (hemiplegic migraine, migraine with prolonged aura, migrainous infarction) 1